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Abstract
Although microRNAs are commonly known to function as a component of RNA-induced silencing complexes in the
cytoplasm, they have been detected in other organelles, notably the nucleus and the nucleolus, of mammalian cells. We
have conducted a systematic search for miRNAs in HeLa cell nucleoli, and identified 11 abundant miRNAs with a high level
of nucleolar accumulation. Through in situ hybridisation, we have localised these miRNAs, including miR-191 and miR-484,
in the nucleolus of a diversity of human and rodent cell lines. The nucleolar association of these miRNAs is resistant to
various cellular stresses, but highly sensitive to the presence of exogenous nucleic acids. Introduction of both single- and
double-stranded DNA as well as double stranded RNA rapidly induce the redistribution of nucleolar miRNAs to the
cytoplasm. A similar change in subcellular distribution is also observed in cells infected with the influenza A virus. The
partition of miRNAs between the nucleolus and the cytoplasm is affected by Leptomycin B, suggesting a role of Exportin-1
in the intracellular shuttling of miRNAs. This study reveals a previously unknown aspect of miRNA biology, and suggests a
possible link between these small noncoding RNAs and the cellular management of foreign genetic materials.
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Introduction
MicroRNAs (miRNAs) have emerged as ubiquitous regulators
of gene expression. The latest version of miRbase reveals 1600
unique human miRNAs (Release 19: August 2012); many of them
are highly cell type- or disease-specific [1]. Biogenesis of miRNAs
requires multiple enzymatic complexes located in different
subcellular compartments. Canonically, miRNAs are transcribed
and processed in the nucleus, and matured in the cytoplasm,
where they are incorporated into an RNA-induced silencing
complex (RISC). Engaged RISCs affect the stability and/or
translational potential of mRNA targets [2–3]. Bioinformatic
estimations suggest that up to one-third of all protein-coding genes
in the human genome are under the regulation of at least one
miRNA [4].
The biogenesis and processing of miRNAs are precisely
controlled, but very little is known about the fate of mature
miRNAs beyond their engagement in the RISC. As mammalian
miRNAs are extremely stable [5], it is intriguing how cells can
adjust the functional pool of specific miRNAs on demand. Parallel
analyses of the expression profiles of miRNAs and their target
mRNAs tend to show only weak inverse correlations [6–7]. In fact,
some tissue-specific miRNAs (e.g., miR-363 and miR-124) exhibit
no obvious correlation with the expression levels of their target
genes. This suggests that the cellular concentrations of individual
miRNAs do not necessarily reflect their functional activities. It is
probable that not all the mature miRNA molecules are equally
active, and there may be a level of ‘‘post-maturational’’ regulation
for miRNAs.
The protein complexes responsible for the last steps of miRNA
maturation are, at least in cultured cancer cells, located in the
cytoplasm. Moreover, miRNAs target RNAs to cytoplasmic foci (P
bodies/stress granules) for sequestration and/or degradation [8–
9]. Since it has been generally established that the cytoplasm is the
site of miRNA activity, most researchers assume that all mature
miRNAs are located in the cytoplasm. However, direct experi-
mental evidence to support this belief is weak. In fact, as early as
2004, the Tuschl Lab showed that up to 20% of mature mir-21
could be recovered from isolated nuclei [10–11]. Hwang et al.
(2007) examined the subcellular distribution of 3 mature miRNAs
and observed that as much as 32% to 71% of these miRNAs are
present in the nucleus [12]. By using high throughput approaches,
five recent studies have identified mature human miRNAs in
purified nuclei [13–16]. The nuclear localisation appears to be
restricted to a subset of miRNAs, and an active process that
involves CRM1 (expontin 1), but no functional significance has
been inferred. More importantly, the Pederson Lab has reported
the detection of miR-206 not only in the cell nucleus, but also in
the nucleolus of rat myoblasts [17], which suggest a higher level of
subnuclear targeting. Their lab has recently extended this finding
with a systematic screening of mature miRNAs in rat myoblasts by
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using a microarray technique [18]. This work reports on the
detection of more miRNAs, e.g., miR-351, miR-1 and miR-664 in
rat nucleoli.
The accumulation of miRNAs in the nucleolus is a tantalising
observation. Research in the past decade has established that the
role of the nucleolus, in addition to its well-characterised functions
in ribosome biogenesis, is that of a cellular ‘‘stress sensor’’ [19]. Its
structural integrity and molecular composition appear to coordi-
nate the phenotypic responses to genotoxic stresses. In this study,
we aim to explore the functional connection between miRNA
metabolism and nucleolar structure, especially as miRNAs are
highly sensitive to environmental stress [9]. The analysis on the
dynamics of nucleolar miRNA in cells under stress can provide
good insights for uncovering the biological functions of nucleolar
miRNAs, and contributing to a more detailed understanding of
the cell biology of the nucleolus [20].
We have employed a quantitative real time polymerase chain
reaction (qPCR)-based profiling method to screen for mature
miRNAs in the nucleolus of HeLa cells. We have identified a
group of nucleolar miRNAs that are stably present in the nucleolus
of a panel of human cancer cells as well as in primary fibroblasts.
To investigate whether nucleolar miRNAs are related to nucleolar
stress sensing, we exposed the cells to various reagents, which
range from chemicals to nucleic acids, such as DNA oligos,
double-strand RNAs, and viral infections. Remarkably, we
observed dynamic changes in nucleolar miRNAs, such as miR-
484 and miR-191, upon viral infection. To our knowledge, this is
the first report that demonstrates a potential linkage between
nucleolar miRNAs in combating viruses and mobile genetic
elements in maintaining genome integrity.
Materials and Methods
The protocol for animal work was approved by the Animal
Experimentation Ethics Committee of the Chinese University of
Hong Kong (Permit Number: 09/050/MIS).
Antibodies and Oligonucleotides
The antibodies used for Western blotting included: rabbit
polyclonal anti-fibrillarin (1:1000, Santa Cruz), mouse monoclonal
anti-a2tubulin (1:1000, Sigma), mouse monoclonal anti-b-actin
(1:4000, Sigma), and FUS/TLS (1:1000, Santa Cruz). The
antibodies for immunofluorescence co-staining with miRNAs were
mouse monoclonal anti-PSP1 (1:100, gift from Dr. Archa Fox),
and mouse monoclonal anti-SC35 (1:100, Abcam).
The ISH probes used for nucleolar miRNAs were: hsa-miR-191
with a sequence 59DigN-cag ctg ctt ttg gga ttc cgt tg-39; hsa-miR-
193b with a sequence 59DigN-agc ggg act ttg agg gcc agt t-39; hsa-
miR-484 with a sequence 59DigN-atc ggg agg gga ctg agc ctg a-39;
and hsa-miR-574-3p with a sequence 59DigN-tgt ggg tgt gtg cat
gag cgt g-39. Mature miR-20a was used as the cytoplasmic control
which showed no expression in the nucleolus, and its sequence is
59DigN-cta cct gca cta taa gca ctt ta-39. The sequences of these
miRNAs can be found in the miRbase (http://microrna.sanger.ac.
uk). Meanwhile, a customised U3 probe labelled with 59-
fluorescein was used as the nucleolar control, its sequence was
56-FAM/ggt ttt cgg tgc tct aca cgt t-39, and also with a scrambled
negative miRNA control, and its sequence was 59DigN-g tgt aac
acg tct ata cgc cca-39. The sequence of Actin primers human:
Forward primer 59-cac tct tcc agc ctt cct tcc-39, Reverse primer 59-
agg tct ttg cgg atg tcc ac-39. The sequence of GAPDH primers
human: Forward primer 59-gaa ggt gaa ggt cgg agt-39, Reverse
primer 59-gaa gat ggt gat ggg att tc-39.
Cells, Transfection and Cell Treatments
Human HeLa cells, H1299, HUH7, MCF7, A549, RPE, and
AG06858 human fibroblast cells were obtained from ATCC, and
cultured in Dulbecco’s modified Eagle’s medium (DMEM, Life
technologies) supplemented with 10% fetal bovine serum (Gibco),
2 mM Glutamax and 16Anti-Anti (Gibco) at 37uC with 5% CO2.
To investigate the miRNA stability to various types of stresses, the
HeLa cells were treated with an RNA polymerase I inhibitor
(ActD, 5 mg/ml), DRB (25 mg/ml), antibiotics (puromycin,
100 mg/ml), UVC exposure (100 J/m2), microtubule poison
nocodazole (500 ng/ml), and a DNA damage drug (CPT,
10 mM), respectively. The localisation of miRNAs was monitored
before and after these treatments. To induce genetic stresses,
dsRNA (control siRNA), pcDNA-GFP DNA, and single-stranded
DNA oligos (control inhibitor) were transfected into the HeLa cells
in the same condition.
Primary Fibroblasts Isolation
Fibroblasts were isolated from dermal layer of mouse tails.
Briefly, BALB/c mouse (,25 g) was sacrificed by cervical
dislocation. Mouse tail was rinse with 70% ethanol, and the tip
of mouse tail was cut into 2-mm small pieces and incubated with
0.25% trypsin/PBS for overnight at 4uC. The skin debris was
discarded. Isolated fibroblasts was washed with PBS and placed in
a 6 well plate containing DMEMmedium supplemented with 10%
FBS, 2 mM Glutamax and 16Anti-Anti (Gibco) and cultured for
4 days. The fibroblast was then subcultured on to coverslip, allow
grow for another two days for ISH staining.
RNA Isolation
HeLa nuclei and nucleoli were isolated as previously described
[21]. The total RNA from whole cells, and the nuclei and nucleoli
of HeLa were extracted by TRIzol Reagent based on the
manufacturer’s instructions (life technologies) and quantified by
measuring the absorbance at OD260/280 by ‘‘Nanodrop’’ and
further examined by gel electrophoresis.
miRNA qPCR Profiling
RT-qPCR was performed as previously described [13]. Briefly,
1000 ng of the total RNA from whole cells and nucleoli were
reverse transcribed by using Megaplex RT (Pools A and B)
respectively, followed by real-time amplification by using low
density array (TaqMan) hydrolysis probes in Pools A and B v 2.0–
two 384-well plates, according to the manufacturer’s instructions
(Applied Biosystems). In this study, we define:
Normalised nucleolus/cell ratio = (miRnucleolus/RNU44nu-
cleolus)/(miRcell/RNU44cell)
Where: miRnucleolus =CT value of a miRNA in isolated
nucleolus
miRcell =CT value of this miRNA in whole cell
RNU44nucleolus =CT value of RNU44 in isolated nucleolus
RNU44cell =CT value of RNU44 in whole cell
AGO2 Immunoprecipitation
RISC was immunoprecipitated by using the miRNA Isolation
Kit, Human Ago2 (Wako, Japan) following manufacturer’s
instruction as follows. HeLa cells harvested from one 10 cm dish
were lysed in 1 ml of Cell Lysis Solution. The lysate was then
mixed with 50 ml of Anti Human Ago2 Antibody Beads Solution
and the mixture was incubated for 4 hours at 4uC by rotation.
After that, the beads were washed with 1 ml of Cell Lysis Solution
twice. 50 ml of Elution Solution was then added to beads. After
transferring the supernatant to a new tube, 350 ml of ultrapure
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distilled water (Gibco) and 400 ml of phenol: chloroform:
isopropanol (25:24:1) was added and the tube was centrifuged at
20,000 g for 10 min at room temperature. The supernatant was
transferred to a new tube and 3 ml of ethachinmate, 40 ml of 3 M
sodium acetate and 1 ml of 99.5% ethanol was added. The tube
was centrifuged at 20,000 g for 15 min at 4uC and the pellet was
washed with 1 ml of 70% ethanol. After centrifuging the tube at
20,000 g for 10 mins at 4uC, the pellet was air dried for 10 min.
The isolated RNA was dissolved in 20 ml ultrapure distilled water
(Gibco). Two-step RT-PCR of miR-484 and miR-20a was
performed by using Taqman MicroRNA Assays (life technologies)
with special designed primers for both target miRNAs for reverse
transcription and RT-PCR respectively.
qRT-PCR
The reverse transcription for both control genes were performed
by using High cDNA Reverse Transcription kit (Applied
Biosystems) with random RT primers and the RT-PCR was
performed by using KAPA SYBR FAST qPCR Kit Master Mix
(26) Universal kit with ROX Reference Dye High (KAPA
BIOSYSTEMS) with designed control gene primers.
In situ Hybridization (ISH) and Microscopy
ISH was performed by using specific DIG-labeled miRNA LNA
probes from Exiqon (Vedbaek, Denmark). Briefly, the cells were
first fixed in 4% paraformaldehyde (4uC) for 30 min, followed by
70% ethanol (precooled at 220uC) for at least 16 hrs at 4uC. The
cells were permeablised with 0.1 Triton X-100 (dissolved in PBS)
for 10 min. The washed cells were then prehybridised with a
prehybridisation buffer (46SSC, 25% formamide, 36Denhardt’s
solution, 2% blocking reagents, 0.25 mg/ml yeast tRNA,
0.25 mg/ml salmon sperm DNA) for 30 min at room tempera-
ture, followed by hybridisation at 23uC below the Tm of the LNA
probe for 2 hrs as previously described [22–23]. The cells were
subsequently washed with Washing Buffer I (46 SSC with 0.1%
Tween 20), II (26 SSC), and III (16 SSC) at the hybridisation
temperature. The cells were blocked with a signal enhancer (Life
technologies) for 1 hr at room temperature, and then incubated
with a mouse anti-DIG antibody at a dilution of 1:1000 at 4uC
overnight. The cells were washed with PBS three times to remove
unbounded mouse anti-DIG antibody. Then, the cells were
incubated with a fluorescently labelled secondary antibody
(dilution 1:200). The DNA was stained with Hoechst 33258.
The samples were mounted on a fluorescent mounting medium
(Dako). The images were taken with a Leica TCS-SPE confocal
microscope.
To confirm that the ISH signals were indeed from the specific
hybridisation of the probes with the target RNA, the cells were
grown on glass coverslips, rinsed once with PBS and once with an
ASE buffer (20 mM Tris, pH 7.5, 5 mMMgCl2, 0.5 mM EGTA),
and permeablised by incubation for 20 min at room temperature
with either PBS (mock treatment), RNase (100 mg/ml, Life
technologies) or proteinase K (100 mg/ml, Life technologies).
To monitor the localisation of newly processed miR-484, HeLa
cells were plated at , 26105 cells/ml into 24 well-plates and pre-
miR484 was delivered into the HeLa cells by electroporation
through the ‘‘NEON’’ system with the following conditions:
1005 V, 35 ms width, and 3 pulses(life technologies).
Western Blotting
The samples were mixed with 26 SDS loading buffer, and
denatured at 95uC for 10 min. Proteins were separated on 12%
Novex precast gel (Life technologies), and transferred to the
nitrocellulose membrane. The membrane was blocked with a
blocking buffer (5% (w/v) milk, in PBST buffer) for 1 hr. After a
brief rinse, the membrane was incubated with the primary
antibody in the blocking buffer for 1 hr. The membrane was
washed three times with PBS and incubated with a secondary
antibody for 1 hr. After a thorough wash, the membrane was
developed with an ECL PlusTM detection kit (GE Healthcare).
Gels were imaged by using a Fuji LAS4000 mini chemilumines-
cent imager.
Viral Infection
For the viral titration, influenza A virus strain A/WSN/1933
(H1N1) and A/Duck/Hong Kong/Y280/97 (H9N2) were titrated
by standard plaque assay. Virus infections were carried out at an
MOI of 2 and PBS was used for mock infection. Cells were washed
with PBS and then infected with influenza virus at the indicated
MOIs for 1 hour at 37uC. Cells were washed with PBS and
supplemented with virus culture medium-Eagle’s minimum
essential medium (MEM, Life technologies, US) supplemented
with 1% penicillin-streptomycin, 1 g/ml TPCK-trypsin.Infected
cells were incubated for the indicated time periods at 37uC. All
work with the infectious virus was carried out at Biosafety Level 2
(BSL-2).
Results
Systematic Analysis of the Nucleolar Distribution of
miRNAs in HeLa Cells
Since nucleoli can be effectively isolated from human cell lines
[21], it is possible to detect the presence of mature miRNAs in
these organelles. By using an established protocol, we separated
HeLa cells into cytoplasmic and nuclear fractions, which were
further separated into nucleoli and nucleoplasm (Figure 1A). Total
RNA was then isolated from these fractions. The purity of these
subcellular fractions was confirmed by using antibodies against
representative marker proteins (Figure 1B), and the integrity of the
isolated RNA was validated by gel electrophoresis (Figure S1A).
The relative abundance of miRNAs in these fractions was
measured by real-time reverse-transcription PCR (qRT-PCR)
profiling by using primers specifically designed to amplify the
mature form of miRNAs [24]. Among the ,750 human miRNAs
screened, 337 are detectable in the HeLa cells (Table S1). In this
study, we have used snoRNA U44 (RNU44), a small RNA known
to be highly enriched in the nucleolus as a loading control. In
effect, our quantitation approach does not aim to measure the
absolute distribution ratio of miRNAs between the nucleolar and
non-nucleolar fraction, but to compare the nucleolar localization
of miRNAs to that of RNU44. A miRNA with the same level of
nucleolar accumulation as RNU44 has a normalized nucleolus/
cell ratio of 1. Some miRNAs, such as miR-1275, have nucleolus/
cell ratios that exceed one. We interpret these miRNAs as being
even more nucleolus-enriched, or more tightly associated with
isolated nucleoli than RNU44. This method provides a convenient
system of ranking miRNAs according to their nucleolar accumu-
lation. To estimate the contribution of non-nucleolar RNAs in the
isolated nucleoli due to contamination during subcellular fraction-
ation, we conducted qRT-PCR with primers specific for two
mRNAs (GAPDH and b-actin) on isolated nucleoli and whole
HeLa cells. After normalisation with RNU44, the nucleolus/cell
ratios of GADPH and b-actin are 0.23 and 0.26 respectively
(Table S1). We therefore restricted our further analyses to
miRNAs with normalized nucleolus/cell ratios of above 0.30,
i.e., those with nucleolar distributions more than 30% of RNU44
and are significantly highly than those of typical mRNAs. Out of
the 337 miRNAs detected in HeLa, 48 miRNAs satisfied this
Dynamics of Nucleolar MicroRNAs
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criterion. To further eliminate potential false-positives, we
restricted our analysis to the miRNAs in which the cycle thresholds
(Cts) in nucleolar fractions are below 30 cycles, as the quantitation
of nucleolus/cell ratios can be highly inaccurate for non-abundant
miRNAs (Figure 1C). Even under such stringent criteria, 11
miRNAs can be identified as miRNAs that are detectable in the
nucleolus with very high levels of confidence (Figure 1D, Table
S2). Since the detected nucleolar contents of many of these RNAs
are very high, we termed these 11 miRNAs as ‘‘nucleolar
miRNAs’’.
Analyses of the sequences, putative targets and chromosome
locations of these miRNAs showed no obvious similarities (Table
S2). In consistent with Liao et al [14], we failed to observe the 39
end hexanucleotides, reported by Hwang et al [12] to be
important in the nuclear localization of miRNAs, in these
nucleolar miRNAs, implying that a mechanism other than that
directed by hexanucleotides is involved in the accumulation of
miRNAs in the nucleolus. Furthermore, the nucleolar distribution
of miRNAs is not significantly correlated with their cellular
abundances (Figure S2). Interestingly, two of the identified
miRNAs, miR-1274a and miR-1274b, have been recently
identified as degradation products of tRNA [25] and are removed
from the list. Our result nevertheless suggests potential nucleolar
roles of tRNA-derived RNA fragments. Apart from these two
RNAs, other nucleolus-localised miRNAs do not share significant
homologies with known tRNAs (data not shown).
Nucleolar miRNAs in Human Cells
Next, we validated our PCR-based observations by using in situ
hybridisation, thus avoiding the potential errors intrinsic to
subcellular fractionation. The small size of mature miRNAs
presents specificity problems for ISH detection. In this study, we
used locked-nucleic acid (LNA)-modified oligonucleotide probes,
which are superior to conventional probes in their thermal
stability, enabling a much higher Tm (as high as 80uC). This
minimises non-specific binding for short oligo hybridization. This
technology has been used in a large number of studies on the
detection of mature miRNAs [26–27]. To counter-stain the
nucleolus, we performed a dual coloured ISH, in which U3
snoRNA was used as the nucleolar marker. Four nucleolar
miRNAs; miR191, miR-484, miR-574-3p and miR-193b, were
tested in our ISH experiments, and all four miRNAs exhibit strong
nucleolar localisation (Figure 2A). The miRNA identified in the
qPCR screen to be nucleolus-excluded, miR-20a, was indeed
found by ISH to be mostly cytoplasmic. A control probe, made up
of a scrambled sequence, showed no detectable hybridisation
(Figure 2A). The ISH signal in the nucleolus was eliminated by
RNase treatment, confirming that the nucleolar signal was due to
the hybridization of the probes to their RNA targets. Protease
treatment did not remove the hybridization signal but led to a
dispersal of the staining pattern, possibly as a result of the general
degradation of cellular organisation (Figure S3A). Over-expression
of the precursor of miR484 in the HeLa cells increased the
nucleolar level of miR-484 (Figure S3B), which suggests that the
Figure 1. Detection of mature miRNAs in the HeLa nucleolus. (A) Nucleoli of HeLa cells are purified with a two-step protocol. Total RNAs are
extracted from the whole cells and purified nucleoli of HeLa, and qRT-PCR based microRNA profiling is performed. (B) The purification and protein
recovery of the subcellular fractions are analysed by SDS-PAGE and Western blotting by using antibodies against known subcellular markers. C: Whole
cell, Cp: Cytoplasm, Nu: Nucleus, Np: Nucleoplasm, No: Nucleolus. (C) The abundance ratios of the detected miRNAs in nucleolus vs. whole cells are
plotted against their abundance in the nucleolus. The box encompasses the miRNAs with high nucleolar abundance (Ct smaller than 30) and
nucleolar/cell ratio that exceeds 0.3. (D) Identities of the selected miRNAs.
doi:10.1371/journal.pone.0070869.g001
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detected nucleolar signals are indeed a result of the maturation of
this precursor.
The mammalian nucleolus comprises three major compart-
ments, fibrillar centre (FC), dense fibrillar component (DFC) and
granular component (GC) [28]. Nucleolar miRNAs display a
intranucleolar pattern similar to that of the muscle-specific miR-
206, a nucleolar miRNA colocalised with 28S RNA in the GC
region [17]. However, we observed subtle differences in the
distribution of the ISH signals from miR191 and that of U3
snoRNA, another known GC component (Figure 2B), which
suggest that nucleolar miRNAs and snoRNAs may occupy distinct
sub-regions of the GC. We then investigated the location of miR-
484 in the micronuclei that did not contain nucleoli. Retinal
pigment epithelial (RPE) cells were chronically exposed to a low
concentration of the microtubule poison nocodazole in order to
generate micronucleated cells. Each micronucleus encompasses a
subset of human chromosomes [29–30]. The micronucleus with
no nucleolus appeared to be devoid of miR-484 (Figure 2C, yellow
box), which suggests that the nuclear location of this miRNA may
depend on the presence of nucleolar organiser regions (NORs).
Intriguingly, in some micronuclei with clearly visible nucleoli, as
judged by the presence of U3 snoRNA, there was no detectable
miR-484 (Figure 2C, red box). This suggests that the potential
involvement of other factors in the nucleolar targeting of miR-484.
We examined the subcellular distribution of these miRNAs in
other human cell lines (Figure 3A), such as lung cancer cell line
H1299 and liver cancer cell line Huh7 and in non-transformed
cells including RPE cells, human fibroblast cell AG06858 and in
freshly isolated mouse primary fibroblasts. The nucleolar location
of these miRNAs was found in all the cell lines tested and
homogeneously detected in all the cells in the culture, which
suggest that the distribution of these miRNAs is independent of
cell cycle stages or other intra-population variations. In addition,
we showed the presence of these miRNAs in the nucleolus of the
canine cell line MDCK (Figures S5B–C), which suggests a level of
evolutionary conservation of the nucleolar localisation of these
miRNAs. Taken together, the nucleolar accumulation of miRNAs
appears to be a widespread phenomenon in cultured mammalian
cells.
Nucleolar miRNAs are Less Engaged in RISC
The differential subcellular locations of miRNAs suggest that
different miRNAs may adopt different post-maturation fates. The
most well-characterised function of miRNAs is their RNA
suppression activities through the incorporation into RISC. We
asked whether nucleolar miRNAs are engaged in RISC to the
same extent as miRNAs that are predominately cytoplasmic. As
shown in Figure 4A, the total cellular content of miR-484 and
miR-20a, miRNAs that are shown to be clearly nucleolar and
cytoplasmic respectively (Figure 2A), are comparable. However,
significantly more miR-20a was detected in RISC isolated by
AGO2 immunoprecipitation than miR-484. When these qRT-
PCR data were translated into fold-enrichment of the respective
miRNAs in the isolated RISC (Figure 4B), we observed that miR-
20a was about 6 times more likely than miR-484 to be co-purified
with RISC. This result suggests that miR-484, and possibly other
nucleolar miRNAs, are less efficient than cytoplasmic miRNAs in
their incorporation in RISC, possibly because of the inaccessibility
of the protein components of RISC which are predominately
cytoplasmic.
Nucleolar miRNAs are Stably Associated with the
Nucleolus
Apart from its well-established role in ribosomal biogenesis, the
nucleolus is increasingly recognised as the sequestration site for
proteins. The reduced efficiency of nucleolar miRNAs in binding
Figure 2. Nucleolar location of mature miR-191, miR-193b, miR-484 and miR-574-3p in HeLa cells. (A) HeLa cells are co-hybridised with
DIG-labeled miRNA probes (red) and an FITC labelled probe for U3 snoRNA (green). Four nucleolar microRNAs; miR-191, miR-193, miR-484, miR-574-
3p, are examined for their nucleolar location. Cytoplasmic microRNA control miR-20a and a scrambled negative (f) control are also included. The
nuclei are stained with Hoechst 33258 (blue). (B) Line profiles of the fluorescence signals of miR-484 (red) and U3 snoRNA (green) in the nucleolus. (C)
Micronucleated RPE cells labelled with probes for miR-484 (red) and U3 (green). The micronuclei are stained with Hoechst 33258 (blue). The yellow
box highlights a micronucleus without a nucleolus. The red box shows a micronucleus with a nucleolus, but with no miR-484 staining. Scale bars:
10 mm.
doi:10.1371/journal.pone.0070869.g002
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to RISC implies that the nucleolar accumulation may represent a
way of sequestrating these mature miRNAs away from their sites
of action. To test this hypothesis, we exposed HeLa cells to a
variety of chemical stresses known to induce nucleolar disruption
[21,31–33], and examined their impact on the location of one of
the nucleolar miRNAs, miR-484. The cells were counter-stained
with an antibody against PSPC1, the marker protein of
paraspeckles, a structure highly sensitive to cellular stress [34].
The nucleolar location of miR-484 was not affected by treatments
with transcription inhibitors Actinomycin D (ActD), 6-dichloro-1-
Figure 3. Nucleolar miRNAs are a widespread phenomenon. (A) Localisation of miR-193b, miR-484 and miR-574-3p is examined in lung cancer
cells H1299, liver cancer cells Huh7, RPE cells, human adult fibroblast AG06858 and primary mouse adult fibroblast. (B) Intracellular distribution of
miR-484 (red) is detected in the HeLa cells 8 hours after exposure to UV (100 J/m2), or treated with ActD (5 mg/ml, 2 hrs), or DRB (25 mg/ml, 2 hrs).
PSP1 (green) is used to confirm the effect of the treatments. The cell nuclei are counterstained with Hoechst 33258 (blue). Scale bars: 10 mm.
doi:10.1371/journal.pone.0070869.g003
Dynamics of Nucleolar MicroRNAs
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beta-D-ribofuranosyl -benzimidazole (DRB), UV, Nocadozole and
topoisomerase inhibitor Camptothecin (CPT) (Figure 3B). Hence,
the accumulation of miR-484, and possibly other nucleolar
miRNAs, in the nucleolus appears to be highly resistant to various
forms of metabolic perturbations, which implies that these
miRNAs are tightly integrated into the nucleolar structure. The
stability of the nucleolar localisation of these miRNAs is also
illustrated by the fact that their discovery was based on their
presence in isolated nucleoli. Their associations with the nucleolar
structure must therefore be strong enough to withstand the
procedure of subcellular fractionation.
Nucleolar Location of miRNAs Responds to Exogenous
Genetic Materials
During our experiments on cellular stress, we examined the
intracellular distribution of miR-484 in cells challenged with
foreign nucleic acids. Unexpectedly, the introduction of a short
double stranded RNA (dsRNA) with no known human homology
effectively changes the intranuclear distribution of miR-484
(Figure 5A), from nucleolar to cytoplasmic. The change was
detectable in a small portion of cells as early as 48 hrs after
transfection and pertained for up to 3 days, with no observable
changes in cell viability and growth rate (data not shown). This
effect on miR-484 localisation was not observed in mock-
transfection (Figure S4A, upper panels), and did not depend on
the method of transfection, as dsRNA delivered by both
electroporation- or Lipofectamine-mediated transfection caused
the same changes (data not shown). Similar changes were also
observed when cells were transfected with other types of nucleic
acid, such as single stranded and plasmid DNAs (Figure S4A–B).
In particular, the use of a DNA plasmid that encodes for Green
Fluorescent Protein (GFP) allowed us to assess the impact of the
amount and the expression of exogenous DNA on the subcellular
localization of nucleolar miRNAs. Some of the transfected cells
expressed a much higher level of GFP (strong whole cell
fluorescence) than others (weaker and predominantly cytoplasmic
fluorescence). However, there is no obvious correlation of the level
of miR-484 redistribution and GFP expression level (Figure S4A,
lower panels). It is possible that the distribution of other nucleolar
miRNAs also respond in the same manner, as another nucleolar
miRNA, miR-191, also re-distributed following transfection
(Figure S4B).
Our data demonstrated the dramatic impact of exogenous
genetic materials on the intracellular distribution of mature
miRNAs. However, transfection is a non-physiological process,
in which the level of cellular stress and the amount of nucleic acid
delivery are difficult to control. To confirm the effect of exogenous
nucleic acids on miRNA localisation, we adopted a more
physiological approach, which involves the use of viral infection.
We infected A549, a lung cancer cell with A/Duck/Hong Kong/
Y280/97 (H9N2) influenza virus and then examined the
localisation of miR-484. As shown in Figure 5B, miR-484 shows
a dramatic redistribution from the nucleolus to nucleoplasm, and
then to the cytoplasm within 5 hrs after infection. Viral infection
of the cells was confirmed by nucleoprotein (NP) staining
(Figure 5B). Similarly, the translocation of miR-484 was also
observed after infection with a human influenza virus (A/WSN/
33), in the A549 cells (Figure S5A) and in cell lines, MDCK
(Figures S5B–C) and HeLa (data not shown). These data suggest
that the nucleolar distribution of miRNAs, although highly
resistant to a wide range of chemically induced stresses, is sensitive
to the specific genomic stress induced by exogenous nucleic acids.
Subcellular Distribution of Nucleolar miRNAs Depends on
Exportin-1 Activity
The miRNA redistribution after transfection and viral infection
suggests a dynamic distribution of these miRNAs between the
nucleus and cytoplasm. Since Exportin-1 can be coprecipitated
with AGO-1 and AGO-2 [35], we asked whether this exportin is
involved in the regulation of the nucleocytoplasmic partitioning of
nucleolar miRNAs. As exportin-1 dependent nuclear export is
sensitive to Leptomycin B (LMB) [36], we treated HeLa cells with
Figure 4. miR-484 and miR-20a bind to RISC with different efficiency. (A) Relative abundance of miR-484 and miR-20a determined by qRT-
PCR in unfractionated HeLa cells and in AGO2 immunoprecipitates. (B) Enrichment factors of miR-484 and miR20a in AGO2 immunoprecipitates,
converted from the qRT-PCR data.
doi:10.1371/journal.pone.0070869.g004
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20 nM LMB for 6 hrs and then probed for the location of miR-
484 by ISH. As shown in Figure 5C, there is virtually no
cytoplasmic miR-484 after LMB treatment, which suggests that
this miRNA may shuttle between the nucleus and cytoplasm,
mediated by the exportin-1 pathway. Our data corroborate with
previous observations in that the nucleocytoplasmic distribution of
miR-16 and miR-29b can be changed by LMB [35].
Previous studies have established that pre-miRNAs are exported
into the cytoplasm via Exportin-5 [37], where they are further
processed into mature miRNAs. Our data suggest that a subset of
mature miRNAs can be imported to the nucleolus by an unknown
mechanism. The nucleolar pool of miRNAs can be re-exported to
the cytoplasm via Exportin-1 (Figure 6). The presence of
exogenous nucleic acids can effectively disrupt this shuttling
process, and deplete the nucleolus of miRNAs. It is possible that
these foreign nucleic acids may saturate the nuclear import
mechanism of small RNAs, or stimulate the export of miRNAs
from the nucleus (Figure 6).
Discussion
In this study, 11 abundant miRNAs are identified in the
nucleolus of HeLa. It is the first work on human cells showing the
nucleolar localization of miRNAs. The presence of miRNAs in the
nucleolus has been reported in other mammals [17–18]. The
Pederson Lab identified more than 50 miRNAs that are highly
enriched in the nucleolus of rat myoblast cells [18]. Three out of
the 11 nucleolar miRNAs identified in our study, including miR-
191 and miR-484, are also on their list (Table S1). This is a
remarkable level of overlapping, given the cell type-specificity of
mammalian miRNAs [38]. We have demonstrated here the
nucleolar localisation of mature miRNAs in a wide diversity of
human, mouse and canine cell lines, regardless of cell types and
transformation status. This suggests that the localisation of
miRNAs in nucleoli is a general phenomenon in mammalian
cells, rather than a unique property of myogenic cells. The
nucleolus is a very dynamic structure [21,39]. Activities of a wide
range of proteins, including MDM2 [40], ADAR2 [41], HAND1
[42] and RelA [43], are controlled by their nucleolar localisation,
possibly through a mechanism mediated by a noncoding RNA
encoded in the ribosomal intergenic region [44]. Moreover, the
nucleolar structure can be reversibly disrupted in response to
cellular stress, which allows sequestered nucleolar factors to
disperse out [34,45–46]. In this report, we show for the first time
that the nucleolar location of mature miRNAs is also highly
dynamic. Although nucleolar miRNAs were not affected by
metabolic perturbations known to disrupt the nucleolar structure,
a single dose of exogenous nucleic acid was sufficient to disperse
Figure 5. Dynamic nucleolar localisation of miR-484. (A) ISH of miR-484 and U3 in HeLa cells 72 hrs after transfection with a scrambled siRNA.
(B) Lung cancer cells A549 are infected with influenza A/Duck/HongKong/Y280/97 (H9N2) strain (MOI = 2) for 1 hr or 5 hrs, respectively. The
successful infection of influenza A virus is indicated by viral NP staining. (C) LMB decreases cytoplasm miR-484. The HeLa cells are incubated with or
without LMB (20 nM) for 6 hrs, and then fixed for ISH staining. SC35 is a nuclear speckle marker used to confirm the effect of LMB. Cell nuclei are
stained with Hoechst 33258 (Blue). Scale bars: 10 mm.
doi:10.1371/journal.pone.0070869.g005
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these miRNAs into the nucleoplasm and cytoplasm. Future studies
will include a detailed investigation on the possible roles of the type
and sequence of nucleic acids in this phenomenon. The functional
significance of this redistribution is still not clear. The need to
manage foreign genomes and their degradation products may
saturate the same molecular machineries used for the subcellular
partitioning of miRNAs. Interestingly, we showed that miR-484, a
nucleolar miRNA, is much less efficient in the binding to RISC
when compared to miR-20a, a cytoplasmic miRNA. This suggests
that the displacement of miRNAs from the nucleolus to the
cytoplasm makes them accessible to RISCs and the sites of
translational suppression.
The rapid redistribution of miRNAs after influenza A viral
infection offers a tantalising perspective on the functional link
between the intracellular targeting of miRNAs and the defense
against viral infection. Interestingly, IFNAR1, an interferon
receptor, is identified by six different miRNA target prediction
algorithms as a target of miR-484 (http://www.umm.
uniheidelberg.de/apps/zmf/mirwalk/micrornapredicted-target.
html). IFNAR1 is known to be down-regulated after influenza A
infection [47–48], possibly through the activation of miR-484. In
future studies, we will experimentally test whether the expression
of IFNAR1 is under the control of miR-484. We will over-express
or knock down miR-484, and then monitor the potential changes
of IFNAR1 level. We will also examine the progression of
influenza A infection after the knockdown of nucleolar miRNAs.
Investigating the interactions between RNA viruses and the
nucleolus will facilitate the design of novel anti-viral therapies,
such as recombinant vaccines and therapeutic molecular inter-
ventions, and also contribute to a more detailed understanding of
the cell biology of the nucleolus [20].
Numerous reports on the profiling of miRNA expression in
different tissues have been published. In those experiments, the
abundance of a certain miRNA is usually used to correlate with
disease states or physiological conditions. However, this popular
approach is based on a hidden assumption that the detectable
cellular abundance of a miRNA represents its entire functionally
active pool. Our data show this is not necessarily the case. Here,
we have shown here that miRNAs are dynamically partitioned
into different intracellular pools. As the functional differences of
miRNAs located in different organelles are unknown, some of
these miRNA expression studies may yield potentially misleading
conclusions. We believe the subcellular distribution of mature
miRNAs shown in this and other reports [13–16,18] should
initiate cautions in designing and interpreting miRNA profiling
experiments. Notably, miR-191 and miR-484, two of the nucleolar
miRNAs revealed in this study, have been suggested as internal
references for miRNA profiling [49–51], possibly because of their
high abundance. Their predominant nucleolar localisation implies
these miRNAs may play non-canonical roles and are not suitable
as a general reference for the quantitation and characterisation of
other miRNAs.
Supporting Information
Figure S1 Quality of RNA used in the qRT-PCR miRNA
profiling experiment. Total RNAs are extracted from whole cells,
and purified nuclei and nucleoli and the quality of RNA from the
three samples are checked by electrophoresis in agarose gel. ‘‘C’’,
Figure 6. The intracellular dynamics of miRNAs.
doi:10.1371/journal.pone.0070869.g006
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whole HeLa cell, ‘‘Nu’’, purified HeLa nuclei, ‘‘No’’ purified
HeLa nucleoli.
(TIF)
Figure S2 Correlation of the normalized nucleolus/cell ratios of
the miRNAs with their Ct values detected in total HeLa cells.
(TIF)
Figure S3 ISH signal of miR-484 is sensitive to RNase A and
delivery of pre-miR-484 increases nucleolar miR-484 in HeLa
cells. Cells are incubated for 20 min at room temperature with
either PBS (mock treatment), RNase A (100 mg/ml, Invitrogen) or
Proteinase K (100 mg/ml, Promega) and further fixed for ISH
staining. The HeLa cells are also transfected with 25 nM pre-miR-
484 by a NEON transfection system. Post transfection (6 hrs), they
are fixed and analysed by ISH staining. Nucleolar marker, U3 is in
green and cell nuclei are stained with HOECHST33258. Scale
bars, 10 mm.
(TIF)
Figure S4 Nucleolars miR-484 and miR-191 are sensitive to
exogenous nucleic acids. The HeLa cells were mock-transfected
(A, upper panels) or transfected with 1 mg/ml pCDNA-GFP
plasmid (A, lower panels) for 72 hrs, or transfected with a single
stranded short DNA oligo for 20 hrs, 48 hrs and 72 hrs (B), and
fixed and processed for ISH with an miR-484 or miR-191 probe.
The expression of the GFP is also captured (A). The cell nuclei are
stained with HOECHST33258. Scale bars: A, 25 mm, B, 10 mm.
(TIF)
Figure S5 Nucleolars miR-484 and miR-191 rapidly respond to
influenza A virus infection. Influenza A model cell lines A549 - a
human lung cancer cell (A) and MDCK- a dog kidney cells (B, C)
are infected with influenza A/WSN for different times, fixed and
processed for ISH analysis with miR-191 and miR-484 probes.
The cell nucleoli are indicated with U3 snoRNA (green) and the
cell nuclei are stained with HOECHST33258 (Blue). Scale bars,
10 mm.
(TIF)
Table S1 MiRNAs in HeLa. The expression of 750 human
miRNAs in whole HeLa cell and isolated nucleoli were screened.
Data was normalized to a nucleolar control snoRNA U44
(RNU44).
(XLS)
Table S2 Nucleolar miRNAs in HeLa. The genomic location,
validated targets and sequence of the most abundant 11 nucleolar
miRNAs were summarized.
(DOC)
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